Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 30;16(9):6308-6319.
doi: 10.21037/jtd-24-406. Epub 2024 Sep 21.

Sex-related disparities in aortic stenosis from disease awareness to treatment: a state-of-the-art review

Affiliations
Review

Sex-related disparities in aortic stenosis from disease awareness to treatment: a state-of-the-art review

Clare Appleby et al. J Thorac Dis. .

Abstract

This state-of-the-art review aimed to synthesize evidence from various sex-stratified studies on aortic stenosis (AS), focusing on the difference in clinical presentation, anatomical characteristics, pathophysiology, and management of AS. In comparison to men, women with AS are present at later stages, are older, more symptomatic, frailer, and exhibit higher operative risk [Society of Thoracic Surgeons (STS) score]. Women tend to have smaller aortic valve (AV) areas and left ventricular (LV) outflow tract, leading to lower stroke volumes (SVs) than men and have a higher prevalence of paradoxical, low-flow, low-gradient AS. In women, chronic pressure overload due to AS results in concentric LV remodelling and hypertrophy, characterized by reduced LV cavities, higher filling pressures, lower wall stress, and more diastolic dysfunction. Conversely, men exhibit more dilated eccentric LV remodelling and hypertrophy. AVs in women are less calcified but more fibrotic. Moreover, women are often underdiagnosed, have severity underestimated, and experience delays or receive fewer referrals for AV replacement (AVR). However, women tend to benefit from transcatheter AVR (TAVR) with a long-term survival advantage over men, although the incidence of vascular complications and bleeding events in 30 days after TAVR is higher in women. Surgical AVR (SAVR) in women has high operative risk, is technically demanding and has poorer outcomes with increased mortality at 30 days compared to men. According to the STS score and EuroSCORE, the female sex itself is considered a risk factor for SAVR. Therefore, addressing sex-related disparities in AS and increasing awareness among physicians promises improved diagnosis and treatment, facilitating equitable care and the development of sex-specific personalized medicine.

Keywords: Aortic stenosis (AS); sex differences; surgical aortic valve replacement (SAVR); transcatheter aortic valve replacement (TAVR); women.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-24-406/coif). C.A. reports that she received speaker honoraria and has received travel support from Edwards Lifesciences, Medtronic and Boston. S.B. received speaker honoraria from Abbott Vascular, Boston Scientific, Edwards Lifesciences, and Medtronic. IPPMed, Cloppenburg, Germany, represented by P.B., has received honoraria (or research funding) for consultancy and medical writing from Edwards Lifesciences. V.D. received honoraria for lectures, presentations, and speakers from Abbott Vascular, Edwards Lifesciences, GE Healthcare, JenaValve, Medtronic, and Novartis Products & Features. Also, she received research grants from Philips and consultation fees from Edwards Lifesciences, Novo Nordisk, and MSD. H.E. received honoraria for lectures from Edwards Lifesciences. C.G. was supported by research grants from the Novartis Foundation, Switzerland; GE Healthcare, US; Gerresheimer AG, Switzerland; Bayer Pharmaceuticals, Switzerland; AMGEN, Switzerland; and Advisis AG, Switzerland, outside of the submitted work; has received travel support from Siemens Healthineers, Germany, and Biotronik, Switzerland; and has received speaker’s fees from Sanofi Genzyme, France. C.H. received institutional grant/research support from Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, and Meril; received consultant fees and honoraria from Edwards Lifesciences, Boston Scientific, and Meril. J.K. is an employee of Edwards Lifesciences and owns stocks from that company. P.M. is a scientist working for Edwards Lifesciences. T.K.R. received research support for medical writing from IPPMed, Germany. W.W. received honoraria for lectures, presentations, speakers and travel support from Abbott Vascular, Medtronic, and Edward lifesciences; received research consultancy fees and received payment for participation in data safety monitoring board or advisory board from Medtronic. The authors have no other conflicts of interest to declare.

Figures

Figure 1
Figure 1
Difference in haemodynamics and LV characteristics in women with AS. LVOT, left ventricular outflow tract; AVA, aortic valve area; SV, stroke volume; AV, aortic valve; AS, aortic stenosis; LVEF, left ventricular ejection fraction; LVH, left ventricular hypertrophy; LV, left ventricle.

Similar articles

Cited by

  • Understanding Aortic Stenosis and Transcatheter Aortic Valve Replacement in Women.
    Masiero G, Franzone A, Paradies V, Karam N, Fraccaro C, De Biase C, Alasnag M, Botti G, Cascone A, Cid-Alvarez AB, Rudolph TK, Kaluzna-Oleksy M, Manzo-Silberman S, Mehilli J, Stähli BE, Grapsa J, Panaou K, Bellini B, Wykrzykowska JJ, Bleiziffer S, Eltchaninoff H, Gilard M, Chieffo A. Masiero G, et al. Struct Heart. 2025 May 30;9(7):100666. doi: 10.1016/j.shj.2025.100666. eCollection 2025 Jul. Struct Heart. 2025. PMID: 40704359 Free PMC article. Review.

References

    1. Steeds RP, Messika-Zeitoun D, Thambyrajah J, et al. IMPULSE: the impact of gender on the presentation and management of aortic stenosis across Europe. Open Heart 2021;8:e001443. 10.1136/openhrt-2020-001443 - DOI - PMC - PubMed
    1. Stewart S, Chan YK, Playford D, et al. Incident aortic stenosis in 49 449 men and 42 229 women investigated with routine echocardiography. Heart 2022;108:875-81. 10.1136/heartjnl-2021-319697 - DOI - PubMed
    1. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11. 10.1016/S0140-6736(06)69208-8 - DOI - PubMed
    1. Iribarren AC, AlBadri A, Wei J, et al. Sex differences in aortic stenosis: Identification of knowledge gaps for sex-specific personalized medicine. Am Heart J Plus 2022;21:100197. 10.1016/j.ahjo.2022.100197 - DOI - PMC - PubMed
    1. Andell P, Li X, Martinsson A, et al. Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study. Heart 2017;103:1696-703. 10.1136/heartjnl-2016-310894 - DOI - PMC - PubMed